Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Summary

The primary objective of this trial is to compare the survival of patients with metastatic malignant melanoma treated with Taxoprexin Injection to those treated with Dacarbazine. In addition, the response rate to each drug, response duration, time to progression and time to treatment failure will be measured. Toxicity will be evaluated and compared between the two groups.

Timeline

Start

2002-12-06

Primary completion

2007-10-27

Completion

2007-10-27

Outcome

Outcome not reported

Stopped (Enrollment): “Interim analysis determined that the futility boundary had been crossed and there was no reasonable prospect that statistical significance would be achieved if patient accrual continued”

Drugs

Indications